β-catenin mRNA silencing and MEK inhibition display synergistic efficacy in preclinical tumor models

Por Ganesh, Shanthi, Shui, Xue, Craig, Kevin P., Koser, Martin L., Chopda, Girish R., Cyr, Wendy A., Lai, Chengjung, Dudek, Henryk, Wang, Weimin, Brown, Bob D., Abrams, Marc T.
Publicado no Mol Cancer Ther (2017)